Mirati Therapeutics
Why Robinhood?
You can watch MRTX and buy or sell other stocks, ETFs, and their options commission-free!About MRTX
Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer.
MRTX Key Statistics
Stock Snapshot
The current Mirati Therapeutics(MRTX) stock price is $58.70, with a market capitalization of 4.12B. The stock trades at a price-to-earnings (P/E) ratio of -4.80.
On 2026-07-25, Mirati Therapeutics(MRTX) stock opened at —, reached a high of —, and a low of —.
Mirati Therapeutics(MRTX) shares are trading with a volume of 0, against a daily average of 2.31M.
In the last year, Mirati Therapeutics(MRTX) shares hit a 52-week high of $64.41 and a 52-week low of $27.30.
In the last year, Mirati Therapeutics(MRTX) shares hit a 52-week high of $64.41 and a 52-week low of $27.30.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.